Don’t Be Too Alarmed by the New SCOTUS Antibody Ruling
SCOTUS revisits enablement, but Amgen v. Sanofi probably won’t transform patent law on its own.

SCOTUS revisits enablement, but Amgen v. Sanofi probably won’t transform patent law on its own.

Most doctors want a federal medical license. But would the Constitution allow Congress to control accreditation?

We have entered a new stage of erasure of children, of the disabled, and of the vulnerable.

Among several important themes, the need to regulate the access to clinical data of patients, also called “interoperability,” arises as a major one.
